Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Is a |
Propranolol+diuretic |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diuretic (substance) |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Propranolol (substance) |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Is a |
Propranolol hydrochloride + bendrofluazide |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Propranolol hydrochloride |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bendrofluazide - chemical |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bendroflumethiazide (substance) |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Has manufactured dose form |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Is a |
Product containing bendroflumethiazide and propranolol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Has manufactured dose form |
Oral capsule |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Has manufactured dose form |
Modified-release oral capsule |
false |
Inferred relationship |
Some |
|
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
Is a |
Propranolol-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|